An increasing body of evidence suggests that mutation in EAAT1 results in decreased uptake of Glu, which can cause hemiplegia, migraine, ataxia, and epilepsy (Jen et al., 2005; Stacey et al., 2010; Parinejad et al., 2016). This evidence concerns the gene SLC1A3 and epilepsy.